To assess the efficacy and safety of different modalities of bladder instillation in patients with neurogenic bladder practicing intermittent catheterization.
Methods:
A systematic review of the literature were conducted using two databases: Medline via PubMed and Scopus. Articles evaluating bladder instillation in patients with neurogenic bladder, who are practicing intermittent catheterization, were collected and assessed for the efficacy and safety of the studied agent by two different reviewers.
Results:
Among the 1896 studies, eight involving 346 patients with neurogenic bladder, were included in this systematic review according to the PRISMA protocols. Gentamicin, Hyaluronic acid, and Lactobacillus rhamnosus was found to decrease the incidence of urinary tract infections, the former reduced multidrug-resistant organisms. Kanamycin-colistin, showed a drop in the mean incidence of bacteriuria in males only. Trisdine, the only studied antiseptic, significantly reduced bacteriuria. Neomycin, however, showed no efficacy in term of bacteriuria. Regarding safety, when evaluated, no major adverse events were reported with any of the studied modalities.
Conclusion:
Bladder instillations of either antibiotics, antiseptics, hyaluronic acid, or Lactobacillus rhamnosus GG are efficient and safe in patients having neurogenic bladder, with recurrent urinary tract infections and practicing clean intermittent catheterization, with gentamicin being the most recommended product among the different studied agents.
CraggsMDBalasubramaniamAVChungEAL, et al. Aberrant reflexes and function of the pelvic organs following spinal cord injury in man. Auton Neurosci2006; 126–127: 355–370.
2.
AmarencoGSheikh IsmaëlSChesnelC, et al. Diagnosis and clinical evaluation of neurogenic bladder. Eur J Phys Rehabil Med2017; 53: 975–980.
3.
ManackAMotskoSPHaag-MolkentellerC, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn2011; 30: 395–401.
4.
de AzevedoRVMOliveiraEAVasconcelosMM, et al. Impact of an interdisciplinary approach in children and adolescents with lower urinary tract dysfunction (LUTD). J Bras Nefrol2014; 36: 451–459.
5.
RenardJBallariniSMascarenhasT, et al. Recurrent lower urinary tract infections have a detrimental effect on patient quality of life: a prospective, observational study. Infect Dis Ther2014; 4: 125–135.
6.
FoxmanB. The epidemiology of urinary tract infection. Nat Rev Urol2010; 7: 653–660.
7.
AbramsPAnderssonKEBirderL, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn2010; 29: 213–240.
GoetzLLKlausnerAP. Strategies for prevention of urinary tract infections in neurogenic bladder dysfunction. Phys Med Rehabil Clin N Am2014; 25: 605–618, viii.
11.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ2021; 372: n71.
12.
CoxLHeCBevinsJ, et al. Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization. Can Urol Assoc J2017; 11: E350–E354.
13.
HaldorsonAMKeysTFMakerMD, et al. Nonvalue of neomycin instillation after intermittent urinary catheterization. Antimicrob Agents Chemother1978; 14: 368–370.
14.
PearmanJW. The value of kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord injury. Br J Urol1979; 51: 367–374.
15.
PearmanJWBaileyMHarperWE. Comparison of the efficacy of “Trisdine” and kanamycin-colistin bladder instillations in reducing bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol1988; 62: 140–144.
16.
PearmanJWBaileyMRileyLP. Bladder instillations of trisdine compared with catheter introducer for reduction of bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol1991; 67: 483–490.
17.
WikströmMLeviRAntepohlW. Bladder irrigation with chlorhexidine reduces bacteriuria in persons with spinal cord injury. J Rehabil Med2018; 50: 181–184.
18.
CicekNYildizNAlpayH. Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder. J Pediatr Urol2020; 16: 366.e1–366.e5.
19.
GroahSLRoundsAKLjungbergIH, et al. Intravesical Lactobacillus rhamnosus GG is safe and well tolerated in adults and children with neurogenic lower urinary tract dysfunction: first-in-human trial. Ther Adv Urol2019; 11: 1756287219875594.
20.
TractenbergREGroahSLFrostJK, et al. Effects of intravesical Lactobacillus rhamnosus GG on urinary symptom burden in people with neurogenic lower urinary tract dysfunction. PM R. Epub ahead of print 14 August 2020. DOI: 10.1002/pmrj.12470.
21.
HuenKHNik-AhdFChenL, et al. Neomycin-polymyxin or gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on clean intermittent catheterization. J Pediatr Urol2019; 15: 178.e1–178.e7.
22.
DefoorWFergusonDMashniS, et al. Safety of gentamicin bladder irrigations in complex urological cases. J Urol2006; 175: 1861–1864.
23.
AbramsPHashimHTomsonC, et al. The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction. Neurourol Urodyn2017; 36: 2109–2116.
24.
StoffelJTPetersonACSandhuJS, et al. AUA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome End points. J Urol2017; 198: 153–160.
25.
MortonSCShekellePGAdamsJL, et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil2002; 83: 129–138.
26.
TenkePKovacsBBjerklund JohansenTE, et al. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Int J Antimicrob Agents2008; 31(Suppl. 1): S68–S78.
27.
GribbleMJPutermanML. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Am J Med1993; 95: 141–152.
28.
McKibbenMJSeedPRossSS, et al. Urinary tract infection and neurogenic bladder. Urol Clin North Am2015; 42: 527–536.
29.
LeeBSBhutaTSimpsonJM, et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev2012; 10: CD003265. Epub ahead of print 17 October 2012. DOI: 10.1002/14651858.CD003265.pub3.
30.
HåkanssonMÅ. Reuse versus single-use catheters for intermittent catheterization: what is safe and preferred? Review of current status. Spinal Cord2014; 52: 511–516.
GuttmannLFrankelH. The value of intermittent catheterisation in the early management of traumatic paraplegia and tetraplegia. Paraplegia1966; 4: 63–84.
33.
LapidesJDioknoACSilberSJ, et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol1972; 107: 458–461.
34.
NewmanDKNewPWHeriseanuR, et al. Intermittent catheterization with single- or multiple-reuse catheters: clinical study on safety and impact on quality of life. Int Urol Nephrol2020; 52: 1443–1451.
35.
GouldCVUmscheidCAAgarwalRK, et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol2010; 31: 319–326.
36.
SaadatSHShepherdSVan AsseldonkB, et al. Clean intermittent catheterization: single use vs. reuse. Can Urol Assoc J2019; 13: 64–69.
37.
D’HondtFEveraertK. Urinary tract infections in patients with spinal cord injuries. Curr Infect Dis Rep2011; 13: 544–551.
38.
JahromiMSMureAGomezCS. UTIs in patients with neurogenic bladder. Curr Urol Rep2014; 15: 433.
